Avidity Biosciences Announces Inducement Grants Under Nasdaq

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

Related Keywords

San Diego , California , United States , Navjot Rai , Kathleen Gallagher , Linkedin , Twitter , Compensation Committee Of Avidity Board Directors , Avidity Biosciences Inc , Prnewswire Avidity Biosciences Inc , Nasdaq , Antibody Oligonucleotide Conjugates , Compensation Committee , Avidity Biosciences , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Market , Oligonucleotide Conjugates , Nc ,